Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9098|111|6|740-745

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.6, 2015-05, pp. : 740-745

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 3, 2015-03 ,pp. : 324-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-01 ,pp. : 36-44

Karger

Access to resources Recommend Favorite

The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy

By  

COLORECTAL DISEASE, Vol. 17, Iss. 9, 2015-09 ,pp. : 772-778

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-02 ,pp. : 138-142

Karger

Access to resources Recommend Favorite

Ureteral Stenting in Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy as a Routine Procedure: Evidence and Necessity

By  

Urologia Internationalis, Vol. 89, Iss. 3, 2012-08 ,pp. : 307-310

Karger

Access to resources Recommend Favorite